Current situation and future perspectives of treatment of chronic pulmonary aspergillosis
10.12092/j.issn.1009-2501.2021.02.014
- Author:
Nana WANG
1
;
Xiaofeng TAN
1
;
Tao MA
2
;
Yusheng CHENG
3
Author Information
1. Department of General Internal Medicine, Tianjin Hospital
2. Department of Hand and Foot Surgery, Yijishan Hospital of Wannan Medical College
3. Department of Respiratory Medicine, Yijishan Hospital of Wannan Medical College
- Publication Type:Journal Article
- Keywords:
Antifungal treatment;
Chronic pulmonary aspergillosis;
Literature review
- From:
Chinese Journal of Clinical Pharmacology and Therapeutics
2021;26(2):217-222
- CountryChina
- Language:Chinese
-
Abstract:
Chronic pulmonary aspergillosis (CPA) is a serious fungal infection, which complicates pulmonary tuberculosis, chronic obstructive pulmonary disease and sarcoidosis with high mortality. At present, the treatment of CPA include drug treatment and surgical treatment. The treatment plan should be determined by the type, clinical manifestations and surgical indications of the patients. Nevertheless, there is no standard plan, and more research is needed to improve it. Combined with the current literature reports, this article reviews the current and progress in the treatment of CPA.
